22Mar 2022
A novel 12‐hour versus 24‐hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomised controlled trial

A novel 12‐hour versus 24‐hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomised controlled trial

The study compared the efficacy of a 12‐hour versus a 24‐hour regimen of intramuscular magnesium sulfate in the management of eclampsia and preeclampsia. Compared with 24 hours, 12 hours of intramuscular magnesium sulfate showed similar rates of seizures, with fewer side effects and shorter inpatient admission.

  • #gynaecology - ivf

Like

Save

Share